Ultrafiltration for the Management of Acute Decompensated Heart Failure

Journal of Cardiac Failure

Volumn 14, Issue 9, 2008, Pages 754-759

  Wertman, Brett M ^a   Gura, Victor ^a   Schwarz, Ernst R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cardiomyopathy; Heart failure; ultrafiltration

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE;

CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; DEFIBRILLATOR; DISEASE COURSE; HEART FAILURE; HOSPITALIZATION; HUMAN; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; ULTRAFILTRATION;

ACUTE DISEASE; ANIMALS; DISEASE MANAGEMENT; DIURETICS; HEART FAILURE; HEMOFILTRATION; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; ULTRAFILTRATION;

EID: 55249119310     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2008.07.230     Document Type: Review

References (56)

1. O'Connell J.B. The economic burden of heart failure. Clin Cardiol 23 3 Suppl (2000) III6-10
2. American Heart Association. Heart Disease and Stroke Statistics-2005 Update (2005), American Heart Association, Dallas, TX
3. Krumholz H.M., Parent E.M., Tu N., Vaccarino V., Wang Y., Radford M.J., et al. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med 157 (1997) 99-104
4. Lewis C.E., Jacobs Jr. D.R., McCreath H., Kiefe C.I., Schreiner P.J., Smith D.E., et al. Weight gain continues in the 1990s: 10-year trends in weight and overweight from the CARDIA Study. Coronary Artery Risk Development in Young Adults. Am J Epidemiol 151 (2000) 1172-1181
5. Costanzo M.R., Guglin M.E., Saltzberg M.T., Jessup M.L., Bart B.A., Teerlink J.R., et al. UNLOAD Trial Investigators. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 49 (2007) 675-683
6. Bart B.A., Boyle A., Bank A.J., Anand I., Olivari M.T., Kraemer M., et al. Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) Trial. J Am Coll Cardiol 46 (2005) 2043-2046
7. Stevenson W.G., Stevenson L.W., Middlekauff H.R., Fonarow G.C., Hamilton M.A., Woo M.A., et al. Improving survival for patients with advanced heart failure: a study of 737 consecutive patients. J Am Coll Cardiol 26 (1995) 1417-1423
8. Hunt S.A., Abraham W.T., Chin M.H., Feldman A.M., Francis G.S., Ganiats T.G., et al. American College of Cardiology; American Heart Association Task Force on Practice Guidelines; American College of Chest Physicians; International Society for Heart and Lung Transplantation; Heart Rhythm Society. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 112 (2005) e154-e235
9. Fonarow G.C., Abraham W.T., Albert N.M., Stough W.G., Gheorghiade M., Greenberg B.H., et al. OPTIMIZE-HF Investigators and Hospitals. Association between performance measures and clinical outcomes for patients hospitalized with heart failure. JAMA 297 (2007) 61-70
10. Ho K.K., Anderson K.M., Kannel W.B., Grossman W., and Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 88 (1993) 107-115
11. Zannad F., Braincon S., Juilliere Y., Mertes P.M., Villemot J.P., Alla F., and Virion J.M. Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL Study. Epidemiologie de l'Insuffisance Cardiaque Avancee en Lorraine. J Am Coll Cardiol 33 (1999) 734-742
12. Schrier R.W., and Abraham W.T. Hormones and hemodynamics in heart failure. N Engl J Med 341 (1999) 577-585
13. Levine B., Kalman J., Mayer L., Fillit H.M., and Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323 (1990) 236-241
14. 1-Adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure. J Am Coll Cardiol 35 (2000) 56-59
15. Ludwig L.L., Schertel E.L., Pratt J.W., McClure D.E., Ying A.J., Heck C.F., et al. Impairment of left ventricular function by acute cardiac lymphatic obstruction. Cardiovasc Res 33 (1997) 164-171
16. Pratt J.W., Schertel E.R., Schaefer S.L., McClure D.E., Heck C.E., and Myerowitz P.D. Acute transient coronary sinus hypertension impairs left ventricular function and induces myocardial edema. Am J Physiol 271 (1996) H834-H841
17. Rubboli A., Sobotka P.A., and Euler D.E. Effect of acute edema on left ventricular function and coronary vascular resistance in the isolated rat heart. Am J Physiol 267 (1994) H1054-H1061
18. Davis K.L., Laine G.A., Geissler H.J., Mehlhorn U., Brennan M., and Allen S.J. Effects of myocardial edema on the development of myocardial interstitial fibrosis. Microcirculation 7 (2000) 269-280
19. Bemis C.E., Serur J.R., Borkenhagen D., Sonnenblick E.H., and Urschel C.W. Influence of right ventricular filling pressure on left ventricular pressure and dimension. Circ Res 34 (1974) 498-504
20. Belenkie I., Smith E.R., and Tyberg J.V. Ventricular interaction: from bench to bedside. Ann Med 33 (2001) 236-241
21. DiDomenico R.J., Park H.Y., Southworth M.R., Eyrich H.M., Lewis R.K., Finley J.M., et al. Guidelines for acute decompensated heart failure treatment. Ann Pharmacother 38 (2004) 649-660
22. Acosta B., DiBenedetto R., Rahimi A., Acosta M.F., Cuadra O., Van Nguyen A., et al. Hemodynamic effects of noninvasive bilevel positive airway pressure on patients with chronic congestive heart failure with systolic dysfunction. Chest 118 (2000) 1004-1009
23. Colucci W.S., Elkayam U., Horton D.P., Abraham W.T., Boure R.C., Johnson A.D., et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. N Engl J Med 343 (2000) 246-253
24. Sackner-Bernstein J.D., Skopicki H.A., and Aaronson K.D. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 111 (2005) 1487-1491
25. Sackner-Bernstein J.D., Kowalski M., Fox M., and Aaronson K. Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials. JAMA 293 (2005) 1900-1905
26. Francis G.S., Benedict C., Johnstone D.E., Kirlin P.C., Nicklas J., Liang C.S., et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 82 (1990) 1724-1729
27. Francis G.S., Siegel R.M., Goldsmith S.R., Olivari M.T., Levine T.B., and Cohn J.N. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohormonal axis. Ann Intern Med 103 (1985) 1-6
28. McCurley J.M., Hanlon S.U., Wei S.K., Wedam E.F., Michalski M., and Haigney M.C. Furosemide and the progression of left ventricular dysfunction in experimental heart failure. J Am Coll Cardiol 44 (2004) 1301-1307
29. Ellison D.H. Diuretic therapy and resistance in congestive heart failure. Cardiology 96 (2001) 132-143
30. Mitrovic V., Luss H., Nitsche K., Forssmann K., Maronde E., Fricke K., et al. Effects of the renal natriuretic peptide urodilatin (ularitide) in patients with decompensated chronic heart failure: a double-blind, placebo-controlled, ascending-dose trial. Am Heart J 150 (2005) 1239
31. Mitrovic V., Seferovic P.M., Simeunovic D., Ristic A.D., Miric M., Moiseyev V.S., et al. Haemodynamic and clinical effects of ularitide in decompensated heart failure. Eur Heart J 27 (2006) 2823-2832
32. Dormans T.P., Huige R.M., and Gerlag P.G. Chronic intermittent haemofiltration and haemodialysis in end stage chronic heart failure with oedema refractory to high dose furosemide. Heart 75 (1996) 349-351
33. Krishnan A., and Oreopoulos D.G. Peritoneal dialysis in congestive heart failure. Adv Perit Dial 23 (2007) 82-89
34. Simpson I.A., Rae A.P., Simpson K., Gribben J., Boulton Jones J.M., Allison M.E., et al. Ultrafiltration in the management of refractory congestive heart failure. Br Heart J 55 (1986) 344-347
35. Forni L.G., and Hilton P.J. Continuous hemofiltration in the treatment of acute renal failure. N Engl J Med 336 (1997) 1303-1309
36. Hariman R.J., Bremner S., Louie E.K., Rogers W.J., Kostis J.B., Nocero M.A., et al. Dose-response study of intravenous torsemide in congestive heart failure. Am Heart J 128 (1994) 352-357
37. Guazzi M.D., Agostoni P., Perego B., Lauri G., Salvioni A., Giraldi F., et al. Apparent paradox of neurohormonal axis inhibition after body fluid volume depletion in patients with chronic congestive heart failure and water retention. Br Heart J 72 (1994) 534-539
38. Blake P., Hasegawa Y., Khosla M.C., Fouad-Tarazi F., Sakura N., and Paganini E.P. Isolation of "myocardial depressant factor(s)" from the ultrafiltrate of heart failure patients with acute renal failure. ASAIO J 42 (1996) M911-M915
39. Jaski B.E., Ha J., Denys B.G., Lamba S., Trupp R.J., and Abraham W.T. Peripherally inserted veno-venous ultrafiltration for rapid treatment of volume overloaded patients. J Card Fail 9 (2003) 227-231
40. Gura V., Beizai M., Ezon C., and Rambod E. Continuous renal replacement therapy for congestive heart failure: the wearable continuous ultrafiltration system. ASAIO J 52 (2006) 59-61
41. Gura V., Ronco C., Nalesso F., Brendolan A., Beizai M., Ezon C., et al. A wearable hemofilter for continuous ambulatory ultrafiltration. Kidney Int 73 (2008) 497-502 Epub 2007 Dec 5
42. Asaba H., Bergstrom J., Furst P., Shaldon S., and Wiklund S. Treatment of diuretic-resistant fluid retention with ultrafiltration. Acta Med Scand 204 (1978) 145-149
43. Rimondini A., Cipolla C.M., Della Bella P., Grazi S., Sisillo E., Susini G., et al. Hemofiltration as short-term treatment for refractory congestive heart failure. Am J Med 83 (1987) 43-48
44. Susini G., Zucchetti M., Bortone F., Salvi L., Cipolla C.M., Rimondini A., et al. Isolated ultrafiltration in cardiogenic pulmonary edema. Crit Care Med 18 (1990) 14-17
45. Marenzi G., Grazi S., Giraldi F., Lauri G., Perego G., Guazzi M., et al. Interrelation of humoral factors, hemodynamics, and fluid and salt metabolism in congestive heart failure: effects of extracorporeal ultrafiltration. Am J Med 94 (1993) 49-56
46. Canaud B., Leblanc M., Leray-Moragues H., Delmas S., Klouche K., and Beraud J.J. Slow continuous and daily ultrafiltration for refractory congestive heart failure. Nephrol Dial Transplant 13 Suppl 4 (1998) 51-55
47. Marenzi G., Lauri G., Grazi M., Assanelli E., Campodonico J., and Agostoni P. Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure. J Am Coll Cardiol 38) (2001) 963-968
48. Sheppard R., Panyon J., Pohwani A.L., Kapoor A., Macgowan G., McNamara D., et al. Intermittent outpatient ultrafiltration for the treatment of severe refractory congestive heart failure. J Card Fail 10 (2004) 380-383
49. Libetta C., Sepe V., Zucchi M., Campana C., and Dal Canton A. Standard hemofiltration improves diuretic responsiveness in advanced congestive heart failure. Cardiology 105 (2006) 122-123
50. Salvatori G., Ronco F., Bonello M., and Bottero M. Management of fluid overload in congestive heart failure: learning from a case report. Int J Artif Organs 29 (2006) 187-196
51. Pepi M., Marenzi G.C., Agostoni P.G., Doria E., Barbier P., Muratori M., et al. Sustained cardiac diastolic changes elicited by ultrafiltration in patients with moderate congestive heart failure: pathophysiological correlates. Br Heart J 70 (1993) 135-140
52. Marenzi G., Guazzi M., Lauri G., Perego G.B., Sganzerla P., and Agostoni P. Body fluid withdrawal with isolated ultrafiltration effects persistent improvement of functional capacity in patients with chronic congestive heart failure. Furosemide does not produce the same result. Cardiologia 39 (1994) 763-772
53. Rogers H.L., Marshall J., Bock J., Dowling T.C., Feller E., Robinson S., and Gottlieb S.S. A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure. J Card Fail 14 (2008) 1-5
54. Guglin M., and Polavaram L. Ultrafiltration in heart failure. Cardiol Rev 15 (2007) 226-230
55. Hillege H.L., Girbes A.R.J., de Kam P.J., Boomsma F., de Zeeuw D., Charlesworth A., et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 102 (2000) 203-210
56. Chatterjee K., and Massie B. Systolic and diastolic heart failure: differences and similarities. J Card Fail 13 (2007) 569-576